|
|
78 Fourth Avenue Waltham, MA 02451 USA phone:(781) 647-5554 fax:(781) 647-5552
|
|
| Symbol |
Private |
| Founded |
0 |
| Employees |
|
|
|
| www.trinepharma.com
|
|
| Research Sector |
Biotech Specialty Pharma |
|
 |
| Summary Description |
| Pharmaceutical products for renal, gastrointestinal and metabolic diseases. |
 |
| Management |
| Mark Skaletsky, Chairman, President and Chief Executive Officer; Timothy P. Noyes, Chief Operating Officer; Elizabeth Grammer, Vice President and General Counsel; Martha J. Carter, RAC, Senior Vice President, Regulatory Affairs; Thomas X. Neenan, Ph.D., Vice President, Business Development |
| |
|
|
| |
|
| Keywords |
| renal, gastrointestinal, metabolic, in-licensing |
|
|
|
| Description |
|
Trine Pharmaceuticals develops and commercializes pharmaceutical products in the areas of renal, gastrointestinal and metabolic diseases. |
 |
| Technology / Differentiation |
| Trine has established a rigorous evaluation system that embraces an integrated, multidisciplinary approach to in-licensing development candidates. The value of this approach is in understanding the key development challenges, identifying important linkages, and constructing a coordinated development plan. |
 |
 |
|
|
|
|
|
|